Business
JP Morgan initiates coverage of Telix Pharmaceuticals. After rising 1,667% in 5 years, is it still a buy?
Image source: Getty Images
Telix Pharmaceuticals Ltd (ASX: TLX) shares have been a standout performer over the past 5 years.
The ASX 200 radiopharmaceutical company has soared a staggering 1,667% over that timeframe.
Over the past year, shares are up 21%.
Early and recent investors in Telix…
Continue Reading
-
Noosa News21 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General21 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News10 hours agoAlternative pathways to university explained
-
Noosa News16 hours agoTributes for woman allegedly mowed down on footpath in Maroochydore; Guilherme Dal Bo charged